276 Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy.
https://stm.sciencemag.org/content/12/530/eaay8329
275 Targeted anti–IL-1β platelet microparticles for cardiac detoxing and repair.
https://advances.sciencemag.org/content/6/6/eaay0589
274 Cardiac stem cell therapy in mouse models of ischaemia–reperfusion injury demonstrates that improvement in heart function is linked to an immune response characterized by the induction of CCR2+ and CX3CR1+ macrophages.
https://www.nature.com/articles/s41586-019-1802-2
273 Alcohol Abstinence in Drinkers with Atrial Fibrillation.
https://www.nejm.org/doi/full/10.1056/NEJMoa1817591?query=featured_home
272 A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.
https://www.nejm.org/doi/full/10.1056/NEJMoa1910355?query=featured_home
271 Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
https://www.nejm.org/doi/full/10.1056/NEJMoa1912388?query=featured_home
270 Restraining cardiotoxic T cells through manipulation of the microbiome transforms inflammatory cardiomyopathy into a targetable disease.
https://science.sciencemag.org/content/366/6467/881
269 Platelet-induced myeloid Socs3 expression in humans and mice contributes to unresolved atherosclerosis inflammation and sustained plaque growth.
https://stm.sciencemag.org/content/11/517/eaax0481
268 Targeting cardiac fibrosis with engineered T cells.
https://www.nature.com/articles/s41586-019-1546-z
267 Cell therapy in a rat model of heart attack is enhanced by stem-cell-derived epicardium.
https://www.nature.com/articles/s41587-019-0197-9
|
